Jan‐Henrik Mikesch

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

Mark J. Levis, Mehdi Hamadani, Brent R. Logan et al. · Journal of Clinical Oncology · 2024 · 153 citations · Full text

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

Christoph Röllig, Michael Krämer, Christoph Schliemann et al. · Blood · 2020 · 133 citations · Full text

EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells

Sareetha Kailayangiri, Bianca Altvater, Stefanie Lesch et al. · Molecular Therapy · 2019 · 123 citations · Full text

A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy

Maxi Wass, Stefanie Göllner, Birgit Besenbeck et al. · Leukemia · 2020 · 95 citations · Full text

Intensive Therapy, Psychoactive Drug, Medicine +6

The Histone Demethylase PHF8 Governs Retinoic Acid Response in Acute Promyelocytic Leukemia

Marı́a Francisca Arteaga, Jan‐Henrik Mikesch, Jihui Qiu et al. · Cancer Cell · 2013 · 85 citations · Full text

Histone Modifications, Chromatin, Cell Regulation +10